This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe

Don't wait – Save up to EUR €1,000 before September 18

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
November 9–11, 2026
KoelnmesseCologne, Germany

Gabriel Flemming
Senior Manager, Healthcare Export Initiative at Germany Trade & Invest
Speaker

Profile

Gabriel Flemming is Senior Manager/Lead Pharmaceuticals and Biotechnology HEALTH MADE IN GERMANY. Prior to this role at Germany Trade & Invest he supported international lifescience companies as an investment consultant expanding their business presence in Germany. The German life sciences and healthcare sector became his industry focus during his time as an IP Acquisition Manager for a boutique consultancy managing the patent value funds of Deutsche Bank. Gabriel holds a Business Administration degree of the University of Munich Business School (LMU, Diplomkaufmann).

HEALTH MADE IN GERMANY is the export initiative for the German healthcare industry. We support international companies and organizations that are interested in establishing contact with potential German partners and suppliers. Set up by the German Federal Ministry for Economic Affairs and Energy (BMWE), the initiative bundles expert market intelligence for easy industry access. One of the initiative’s main goals is to promote the German healthcare sector through international networking activities for the mutual benefit of international partners and German companies alike. The HEALTH MADE IN GERMANY initiative is implemented by Germany Trade & Invest.

Germany Trade & Invest (GTAI) is the economic development agency of the Federal Republic of Germany. With two locations in Germany, 60 offices abroad and its network of partners throughout the world, GTAI supports German companies setting up in foreign markets, promotes Germany as a business location and assists foreign companies setting up in Germany.

Agenda Sessions

  • Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off

    09:30